Portal
Order

MI Cancer Seek® is now available for clinical ordering. Learn more.

Home / Research / Publications / Pan-cancer analysis of YAP1 expression as a predictive biomarker for cancer immunotherapy

Publications

Back

Pan-cancer analysis of YAP1 expression as a predictive biomarker for cancer immunotherapy

– Caris Life Sciences

Poster

Key Finding:

Consistent with observations in small-cell lung cancer, YAP1 expression positively correlates with the ‘T-cell inflamed’ phenotype in 12 additional cancer types. 

Download Publication

Discover
More

  • Real-world multi-omic characterization of small cell lung cancer subtypes reveals differential expression of clinically relevant biomarkers

    – Caris Life Sciences

    Poster

    Background: The dominant expression of four lineage-defining transcription factors (ASCL1, NEUROD1, YAP1, or POU2F3) has enabled the classification of small cell lung cancer (SCLC) into four subtypes (SCLC-A/N/Y/P, respectively).… […]

  • PD-1 and PD-L1 expression in 1599 gynecological malignancies – implications for immunotherapy

    – Caris Life Sciences

    Poster

    Objectives: T-cell suppression via PD-1/PD-L1 interactions plays a central role in cancer progression and survival, making PD-1/PD-L1 attractive therapeutic targets. Clinical trials involving PD-1/PD-L1-targeted immunotherapies… […]
Learn More

Ready to Get Started on the Journey?

Name(Required)